CHADWICK JEREMY G (Chief Operating Officer) sold 28.1% of their position (17.18K shares) of KYMERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.37M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−3.73K
Price / share
$78.36
Trade value
$292.27K
% of position
Common Stock
Shares
−324.00
Price / share
$79.17
Trade value
$25.65K
% of position
Common Stock
Shares
−3.80K
Price / share
$79.39
Trade value
$301.69K
% of position
Common Stock
Shares
−4.50K
Price / share
$80.02
Trade value
$360.11K
% of position
Common Stock
Shares
−551.00
Price / share
$80.71
Trade value
$44.47K
% of position
Common Stock
Shares
−3.68K
Price / share
$81.50
Trade value
$299.85K
% of position
Common Stock
Shares
−600.00
Price / share
$82.08
Trade value
$49.25K
% of position
Net shares
−17.18K
Net value
-$1.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2026 | S · Sale | −3.73K | $78.36 | $292.27K | 6.1% | 61.20K | 57.47K |
| Common Stock Direct | 5/26/2026 | S · Sale | −324.00 | $79.17 | $25.65K | 0.6% | 57.47K | 57.15K |
| Common Stock Direct | 5/26/2026 | S · Sale | −3.80K | $79.39 | $301.69K | 6.6% | 57.15K | 53.35K |
| Common Stock Direct | 5/26/2026 | S · Sale | −4.50K | $80.02 | $360.11K | 8.4% | 53.35K | 48.85K |
| Common Stock Direct | 5/26/2026 | S · Sale | −551.00 | $80.71 | $44.47K | 1.1% | 48.85K | 48.30K |
| Common Stock Direct | 5/27/2026 | S · Sale | −3.68K | $81.50 | $299.85K | 7.6% | 48.30K | 44.62K |
| Common Stock Direct | 5/27/2026 | S · Sale | −600.00 | $82.08 | $49.25K | 1.3% | 44.62K | 44.02K |
| Total | −17.18K | -$1.37M | ||||||